Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

DOI Web Site Web Site 被引用文献6件

収録刊行物

  • The Lancet

    The Lancet 396 (10257), 1090-1100, 2020-10

    Elsevier BV

被引用文献 (6)*注記

もっと見る

問題の指摘

ページトップへ